Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: First experiences with patient perceptions, surveillance behavior and acceptance of genetic testing

Genetic Counseling

Volumn 11, Issue 2, 2000, Pages 127-146

  Hofferbert, S ^a   Worringen, U ^b   Backe, J ^a,c   Ruckert E M ^a   White, K ^a   Faller, H ^b   Grimm, T ^a   Cafeier, H ^c   Chang Claude, J ^d   Weber, Bernhard H F ^a,e  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Inst Psychother und Med Psychol   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Decision making; Familial breast and ovarian cancer; Interdisciplinary genetic counseling; Risk perception

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; DNA DETERMINATION; FEMALE; GENETIC COUNSELING; GERMANY; GYNECOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; ONCOLOGY; OVARY CANCER; TEAMWORK;

EID: 18744432879     PISSN: 10158146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J. Clin. Oncol., 1996, 14, 1730-1736.
2. AMERICAN SOCIETY OF HUMAN GENETICS: Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am. J. Hum. Genet., 1994, 55, i-iv.
3. BICK U.: An integrated early detection concept in women with a genetic predisposition for breast cancer. Radiologe 1997, 37, 591-596.
4. BIESECKER B.B., BOEHNKE M., CALZONE K., MARKEL D.S., GARBER J.E., COLLINS F.S., WEBER B.L.: Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA, 1993, 269, 1970-1974.
5. BOTKIN J.R., CROYLE R.T., SMITH K.R., BATY B.J., LERMAN C., GOLDGAR D.E., WARD J.M., FLICK B.J., NASH J.E.: A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. J. Natl. Cancer Inst., 1996, 88, 872-882.
6. BRANDT J., QUAID K.A., FOLSTEIN S.E., GARBER P., MAESTRI N.E., ABBOTT M.H., SLAVNEY P.R., FRANZ M.L., KASCH L., KAZAZIAN H.H.: Presymptomatic diagnosis of delayed-onset disease with linked DNA markers: the experience in Huntington's disease. JAMA, 1989, 261, 3108-3114.
7. CLAUS E.B., RISCH N., THOMPSON W.D.: Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet., 1991, 48, 232-242.
8. COLLINS F.S.: BRCA1 - Lots of mutations, lots of dilemmas. New Engl. J. Med., 1996, 334, 186-188.
9. CROYLE R.T., SMITH K.R., BOTKIN J.R., BATY B., NASH J.: Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psych., 1997, 16, 63-72.
10. DECRUYENAERE M., EVERS-KIEBOOMS G., VAN DEN BERGHE H.: Perception of predictive testing for Huntington's disease by young women: preferring uncertainty to certainty? J. Med. Genet., 1993, 30, 557-561.
11. DECRUYENAERE M., EVERS-KIEBOOMS G., BOOGAERTS A., CASSIMAN J.J., CLOOSTERMANS T., DEMYTTENANAERE K., DOM R., FRYNS J.P. and VAN DEN BERGHE H.: Predictive Testing for Huntingtons's disease: risk perception, reasons for testing and psychological profile of test applicants. Genet. Couns., 1995, 6, 1-13.
12. DE WERT G: Ethics of predictive DNA-testing for hereditary breast and ovarian cancer. Patient Educ. Couns., 1998, 35, 43-52.
13. DUDOKDE WIT A.C., TIBBEN A., DUIVENVOORDEN H.J., NIERMEIJER M.F., PASSCHIER J., OTHER MEMBERS OF THE ROTTERDAM/LEIDEN GENETICS WORKGROU: Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? J. Med. Genet., 1998, 35, 745-754.
14. DUROCHER F., SHATTUCK-EIDENS D., MCCLURE M., LABRIE F., SKOLNICK M.H., GOLDGAR D.E., SIMAKD J.: Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum. Mol. Genet., 1996, 5, 835-842.
15. EASTON D.F., FORD D., BISHOP D.T., the BREAST CANCER LINKAGE CONSORTIUM: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am. J. Hum. Genet., 1995, 56, 265-271.
16. EASTON D. F., STEELE L., FIELDS P., ORMISTON W., AVERILL D., DALY P.A., MCMANUS R., NEUHAUSEN S.L., FORD D., WOOSTER R., CANNON-ALBRIGHT L.A., STRATTON M.R., GOLDGAR D.E.: Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am. J. Hum. Genet., 1997, 61, 120-128.
17. ENG C.: From Bench to bedside... but when? Genome Res., 1997, 7, 669-672.
18. EVANS D.G., BLAIR V., GREENHALGH R., HOPWOOD P. and HOWELL A.: The impact of genetic counseling on risk perception in women with a family history of breast cancer. Br. J. Cancer. 1994, 70, 934-938.
19. EVERS-KIEBOOMS G., SWERTS A.. CASSIMAN J.J., VAN DEN BERGHE H.: The motivation of at-risk individuals and their partners in deciding for or against predictive testing for Huntington's disease. Clin. Genet., 1989, 35, 29-40.
20. EVERS-KIEBOOMS G., DECRUYENAERE M.: Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals. Patient Educ. Couns., 1998, 35, 15-26.
21. FORD D., EASTON F.: The genetics of breast and ovarian cancer. Br. J. Cancer, 1995, 72, 805-812.
22. FORD D., EASTON D.F., BISHOP D.T., NAROD S.A., GOLDGAR D.E., the BREAST CANCER LINKAGE CONSORTIUM: Risks of cancer in BRCA1 mutation carriers. Lancet, 1994, 343, 692-695.
23. FORD D., EASTON D.F., STRATTON M., NAROD S., GOLDGAR D., DEVILEE P., BISHOP D.T., WEBER B., LENOIR G., CHANG-CLAUDE J., SOBOL H., TEARE M.D., STRUEWING J., ARASON A., SCHERNECK S., PETO J., REBBECK T.R., TONIN P., NEUHAUSEN S., BARKADOTTIR R., EYFJORD J., LYNCH H., PONDER B.A.J., GAYTHER S.A., BIRCH J.M, LINDBLOM A., STOPPA-LYONNET D., BIGNON Y., BORG A., HAMANN U., HAITES N., SCOTT R.J., MAUGARD CM. VASEN H., SEITZ S., CANNON-ALBRIGHT L.A., SCHOFIELD A., ZELADA-HEDMAN M., the BREAST CANCER LINKAGE CONSORTIUM: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet., 1998, 62, 676-689.
24. FOX S., BLOCH M., FAHY M., HAYDEN M.R.: Predictive testing for Huntington disease: I. Description of a pilot project in British Columbia. Am. J. Med. Genet., 1989, 32, 211-216.
25. GAGNON P., MASSIE M.J., KASH K.M., GRONERT M., SIMKOVICH HEERDT A., BROWN K., SULLIVAN M., BORGEN P.: Perception of breast cancer risk and psychological distress in women attending a surveillance program. Psycho-Oncology, 1996, 5, 259-269.
26. GIARDIELLO F.M., BRENSINGER J.D., PETERSEN G.M., LUCE M.C., HYLIND L.M., BACON J.A., BOOKER S.V., PARKER R., HAMILTON S.R.: The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. New Engl. J. Med., 1997, 336, 823-827.
27. GOODNIGHT J.E. JR., QUAGLIANA J.M., MORTON D.L.: Failure of subcutaneous mastectomy to prevent the development of breast, cancer. J. Surg. Oncol., 1984, 26, 198-201.
28. HALLOWELL N., MURTON F.: The value of written summaries of genetic consultations. Patient Educ. Couns., 1998, 35, 27-34.
29. INTERNATIONAL HUNTINGTON ASSOCIATION and WORLD FEDERATION OF NEUROLOGY RESEARCH GROUP ON HUNTINGTON'S CHOREA: Guidelines for the molecular genetics predictive test in Huntington's disease. Neurology, 1994, 44, 1533-1536.
30. KASH K.M., HOLLAND J.C., HALPER M.S., MILLER D.G.: Psychological distress and surveillance behaviors of women with a family history of breast cancer. J. Natl. Cancer Inst., 1992, 84, 24-30.
31. KASH K.M., HOLLAND J.C., OSBORNE M.P., MILLER D.G.: Psychological counseling strategies for women at risk of breast cancer. J. Natl. Cancer Inst. Monogr., 1995, 17, 73-79.
32. KODISH E., WIESNER G.L., MEHLMAN M., MURRAY T.: Genetic testing for cancer risk: how to reconcile the conflicts. JAMA, 1998, 279, 179-181.
33. LEONHARDT A.: Clinical detection of 2511 breast cancers 1977-1986. Efficiency of legal early cancer detection studies. Geburtshilfe Frauenheilkd., 1988, 48, 92-98.
34. LERMAN C., AUDRAIN J., CROYLE R.T.: DNA-testing for heritable breast cancer risks: lessons from traditional genetic counseling. Ann. Behav. Med., 1994, 16, 327-333
35. LERMAN C., KASH K., STEFANEK M.: Younger women at increased risk for breast cancer: perceived risk, psychological well-being and surveillance behavior. J. Natl. Cancer Inst. Monogr., 1994, 16, 171-176.
36. LERMAN C., NAROD S., SCHULMAN K., HUGHS C., GOMEZ-CAMINERO A., BONNEY G., GOLD K., TROCK B., MAIN D., LYNCH J., FULMORE C., SNYDER C., LEMON S.J., CONWAY T., TONIN P., LENOIR G., LYNCH H.: BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA, 1996, 275, 1885-1892.
37. LERMAN C., SCHWARTZ M.D., LIN T.H., HUGHES C., NAROD S., LYNCH H.T.: The influence of psychological distress on use of genetic testing for cancer risk. J. Consult. Clin. Psychol., 1997, 65, 414-420.
38. LOVE R.R.: The National Surgical Adjuvant Breast Project (NSABP) Breast Cancer Prevention Trial revisited. Cancer Epidemiol. Biomarkers Prev., 1993, 2, 403-407.
39. LYNCH H.T., WATSON P., CONWAY T.A., LYNCH J.F., SLOMINSKI-CASTER S.M., NAROD S.A., FEUNTEUN J., LENOIR G.: DNA screening for breast/ ovarian cancer susceptibility based on linked markers: A family study. Arch. Intern. Med., 1993, 153, 1979-1987.
40. LYNCH H.T., LEMON S.J., DURHAM C., TINLEY S.T., CONNOLLY C., LYNCH J.F., SURDAM J., ORINION E., SLOMINSKI-CASTER S., WATSON P., LERMAN C., TONIN P., LENOIR G., SEROVA O., NAROD S.: A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer, 1997, 79, 2219-2228.
41. LYNCH H.T., LEMON S.J., KARR B., FRANKLIN B., LYNCH J.F., WATSON P., TINLEY S., LERMAN C., CARTER C.: Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications. Cancer Epidemiol. Biomarkers Prev., 1997, 6, 987-991.
42. MIKI Y, SWENSEN J., SHATTUCK-EIDENS D., FUTREAL P.A., HARSHMAN K., TAVTIGIAN S., LIU Q.Y., COCHRAN C., BENETT L.M., DING W., BELL R., ROSENTHAL J., HUSSEY C., TRAN T., MCCLURE M., FRYE C., HATTIER T., PHELPS R., HAUGEN-STRANO A., KATCHER H., YAKUMO K., GHOLAMI Z., SHAFFER D., STONE S., BAYER S., WRAY C., BOGDEN R., DAYANANTH P., WARD J., TONIN R., NAROD S., BRISTOW P.K., NORRIS F.H., HELVERING L., MORRISON P., ROSTECK P., LAI M., BARRETT J.C., LEWIS C., NEUHAUSEN S., CANNON-ALBRIGHT L., GOLDGAR D., WISEMAN R., KAMB A., SHOLNICK MH: A strong candidate for the breast and ovarian-cancer susceptibility gene BRCA1. Science, 1994, 266, 66-71.
43. NATIONAL ADVISORY COUNCIL FOR HUMAN GENOME RESEARCH: Statement on use of DNA testing for presymptomatic identification of can-cer risk. JAMA, 1994, 271, 785.
44. NEWMAN B., AUSTIN M.A., LEE M., KING, M.C.: Inheritance of human breast cancer: evidence for autosomal dominant transmission in high risk families. Proc. Natl. Acad. Sci. USA, 1988, 85, 3044-3048.
45. PIVER M.S., JISHI M.F., TSUKADA Y, NAVA G.: Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer, 1993, 71, 2751-2755.
46. PONDER M., GREEN J.M.: BRCA1 testing: some issues from research to service. Psycho-Oncology, 1996, 5, 223-232.
47. POWLES T.J., TILLYER C.R., JONES A.L., ASHLEY S.E., TRELEAVEN J., DAVEY J.B., MCKINNA J.A.: Prevention of breast cancer with tamoxifen - an update on the Royal Marsden Hospital pilot programme. Eur. J. Cancer, 1990, 26, 680-684.
48. REBBECK T.R., COUCH F.J., KANT J., CALZONE K., DESHANO M., PENG Y., CHEN K., GARBER J.E., WEBER B.L.: Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am. J. Hum. Genet., 1996, 59, 547-553.
49. SCHORGE J.O., MUTO M.G., WELCH W.R.: Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J. Natl. Cancer Inst., 1998, 90, 841-845.
50. SCHRAG D., KUNTZ K.M., GARBER J.E., WEEKS J.C.: Decision analysis - effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N. Engl. J. Med., 1997, 336, 1465-1471.
51. SCHWARTZ M.D., TAYLOR K.L., WILLARD K.S., SIEGEL J.E., LAMDAN R.M., MORAN K.: Distress, personality, and mammography utilization among women with a family history of breast cancer. Health Psychol., 1999, 18, 327-332.
52. STEPHENSON J.: Study shows mastectomy prevents breast cancer in high-risk women. JAMA, 1997, 277, 1421-1422.
53. STRUEWING J.P., HARTGE P., WACHOLDER S., BAKER S.M., BERLIN M., MCADAMS M., TIMMERMANN M.M., BRODY L.C., TUCKER M.A.: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New Engl. J. Med., 1997, 336, 1401-1408.
54. SZABO C.I., KING M.-C.: Population genetics of BRCA1 and BRCA2. Am. J. Hum. Genet., 1997, 60, 1013-1020.
55. TAVTIGIAN S.V., SIMARD J., ROMMENS J., COUCH F., SHATTUCK-EIDENS D., NEUHAUSEN S., MERAJVER S., THORLACIUS S., OFFIT K., STOPPA-LYONNET D., BELANGER C., BELL R., BERRY S., BOGDEN R., CHEN Q., DAVIS T., DUMONT M., FRYE C., HATTIER T., JAMMULAPATI S., JANECKI T., JIANG P., KEHRER R., LEBLANC J.-F. MITCHELL J.T., MCARTHUR-MORRISON J., NGUYEN K., PENG Y., SAMSON C., SCHROEDER M., SNYDER S.C., STEELE L., STRINGFELLOW M., STROUP C., SWEDLUND B., SWENSEN J., TENC D., THOMAS A., TRAN T., TRANCHANT M., WEAVER-FELDHAUS J., WONG A.K.C., SHIZUYA H., EYFJORD J.E., CANNON-ALBRIGHT L., LABRIE F., SKOLNICK M.H., WEBER B., KAMB A., GOLDGAR D.E.: The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet., 1996, 12, 333-337.
56. TIBBEN A., FRETS P.G., VAN DE KAMP J.J.P., NIERMEIJER M.F., VEGTER-VAN DER VLIS M., ROOS R.A.C., VAN OMMEN G.J.B., DUIVENVOORDEN H.J., VERHAGE F.: Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program. Am. J. Med. Genet., 1993, 48, 10-16.
57. VANCHIERI C.: Breast cancer prevention study initiated in Italy. J. Natl. Cancer Inst., 1992, 84, 1555-1556.
58. VERNON S.W., VOGEL V.G., HALABI S., BONDY M.L.: Factors associated with perceived risk of breast cancer among women attending a screening program. Breast Cancer Res. Treat., 1993, 28, 137-144.
59. WEBER A.M., HEWETT W.J., GAJEWSKI W.H., CURRY S.L.: Serous carcinoma of the peritoneum after oophorectomy. Obstet. Gynecol., 1992, 80, 558-560.
60. WOOSTER R., BIGNELL G., LANCASTER J., SWIFT S., SEAL S., MANGION J., COLLINS N., GREGORY S., GUMBS C., MICKLEM G., BARFOOT R., HAMOUDI R., PATEL S., RICE C., BIGGS P., HASHIM P., SMITH A., CONNOR F., ARASON A., GUDMUNDSSON J., FICENEC D., KEISELL D., FORD D., TONIN P., BISHOP T.D., SPURR N.K., PONDER B.A.J., EELES R., PETO J., DEVILEE P., CORNELISSE C., LYNCH H., NAROD S., LENOIR G., EGLISSON V., BARKADOTTIT R.B., EASTON D.F., BENTLEY D.R., FUTRAL P.A., ASHWORTH A., STRATTON M.: Identification of the breast cancer susceptibility gene BRCA2. Nature, 1995, 378, 789-792.
61. ZIEGLER L.D., KROLL S.S.: Primary breast cancer after prophylactic mastectomy. Am. J. Clin. Oncol., 1991, 14, 451-454.